Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma

Katarzyna A. Ellsworth; Bruce W. Eckloff; Liang Li; Irene Moon; Brooke L. Fridley; Gregory D. Jenkins; Erin Carlson; Abra Brisbin; Ryan Abo; William Bamlet; Gloria Petersen; Eric D. Wieben; Liewei Wang

doi:10.1371/journal.pone.0070216

Loading metrics

Open Access

Peer-reviewed

Research Article

Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma

Katarzyna A. Ellsworth,

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Bruce W. Eckloff,

Affiliation Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Liang Li,

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Irene Moon,

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Brooke L. Fridley,

Current address: Department of Biostatistics, University of Kansas Medical Center, Kansas City, Kansas, United States of America

Affiliation Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Gregory D. Jenkins,

Affiliation Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Erin Carlson,

Affiliation Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Abra Brisbin,

Affiliation Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Ryan Abo,

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
William Bamlet,

Affiliation Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Gloria Petersen,

Affiliation Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Eric D. Wieben,

Affiliation Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, United States of America
⨯
Liewei Wang

* E-mail: wang.liewei@mayo.edu

Affiliation Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, Rochester, Minnesota, United States of America
⨯

Contribution of FKBP5 Genetic Variation to Gemcitabine Treatment and Survival in Pancreatic Adenocarcinoma

Katarzyna A. Ellsworth,
Bruce W. Eckloff,
Liang Li,
Irene Moon,
Brooke L. Fridley,
Gregory D. Jenkins,
Erin Carlson,
Abra Brisbin,
Ryan Abo,
William Bamlet

Published: August 1, 2013
https://doi.org/10.1371/journal.pone.0070216

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Single nucleotide polymorphisms
Is the Subject Area "Single nucleotide polymorphisms" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Pancreatic cancer
Is the Subject Area "Pancreatic cancer" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Genetic polymorphism
Is the Subject Area "Genetic polymorphism" applicable to this article?

Thanks for your feedback.
Functional genomics
Is the Subject Area "Functional genomics" applicable to this article?

Thanks for your feedback.
Transcription factors
Is the Subject Area "Transcription factors" applicable to this article?

Thanks for your feedback.
Human genetics
Is the Subject Area "Human genetics" applicable to this article?

Thanks for your feedback.